Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion type Assertion NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_head.
- NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion description "[Furthermore, NEFL physically associated with tuberous sclerosis complex 1 (TSC1), a known inhibitor of the mTOR pathway, and NEFL downregulation led to functional activation of mTOR pathway and consequentially conferred cisplatin resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_provenance.
- NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion evidence source_evidence_literature NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_provenance.
- NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion SIO_000772 22246235 NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_provenance.
- NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion wasDerivedFrom befree-20150227 NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_provenance.
- NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_assertion wasGeneratedBy ECO_0000203 NP587178.RAbddhbO02F54RPJ7e6OgpYL2NQrXCl2TkxFzqu1hPpVE130_provenance.